Acceleration of Cancer and Ophthalmic Treatments

participants

Team

Participants

People working for people’s health
Scientists in charge

ACADEMIC

Breandan Kennedy

COORDINATOR

University College Dublin

Lasse Jensen

Linköpings Universitet

Jacintha O'Sullivan

Trinity College Dublin

Lorenzo Pastrana

Iberian Nanotechnology Laboratory

Raj Thakur

Queens University Belfast

Abhay Pandit

National University of Ireland Galway

Rocio Herrero

Universidad Complutense de Madrid

Yolanda Diebold

Universidad de Valladolid

Uwe Straehle

Karlsruher Institut für Technologie

Team

NON-ACADEMIC

Alberto Villanueva

XENOPAT

Jesús Pintor

OCUPHARM

Rosemarie Carew

ICON Firecrest

Beatriz de la Parra

ECM Ingeniería Ambiental

Javier Terriente

Zeclinics

Wenxin Wang

BLAFAR

Soledad Anguiano

HGBeyond

Benedicta Von Ingelheim

EPO Berlin

Rafal Farjo

EYECRO

inspiration

"Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less

"

Marie Skłodowska Curie (1867-1934)

partners

Team

Partners

Companies, Institutions & Universities behind people’s health

Team

challenges

Challenges

The 3D-NEONET consortium tackles several challenges which enrich the development of this project.

Inter-European & international knowledge

95%

cross-sector study

100%

7 country's project

96%

Clinical trial and regulatory approval

93%

blog

BLOG FELLOWS

Tale from a Pandemic…

Sticky PostOn 19/10/2020

I feel the scientific community should be prouder than ever to have adapted and to continue fighting against everything that is trying to stop us…

Read More

Being a researcher is not just a job

Sticky PostOn 22/09/2020With No Comments

Once you get into research you can never really stop: there is always something more to study, to learn, some new variable to try or curiosity to satisfy

Read More

Swedish Meatballs

Sticky PostOn 05/08/2020With No Comments

My worries to get into this new experience were unfounded, because everything turned out very good despite the difficulties…

Read More

Read More

READ ALL THE NEWS